Some in Ebola Trials Wouldn’t Get Test Drugs in U.S. Plan
This article is for subscribers only.
U.S. health officials want some patients to forgo potentially life-saving Ebola treatments when they’re being tested so researchers can compare their response to those who get the medicines, said an official involved in the discussions.
Some experimental drugs have already been used on an emergency basis. In a formal trial, the U.S. wants one group of patients to get the treatments and a second to get only standard supportive care, said the official, who asked not to be identified because the person isn’t authorized to speak on the record. Supportive care includes replacing fluids and using medicines to fight off other infections.